The FDA announced on April 20, 2026, that Scope Health is recalling Optase Dry Eye Intense Drops due to a lack of sterility assurance. The agency issued recall number D-0499-2026 for the Class II voluntary recall.
How to tell if you have it
- Brand: Scope Health
- Product: Optase Dry Eye Intense Drops (Glycerin 0.2%)
- Size: 0.33 fl oz
- NDC: 72972-002-01
- Lot codes: 8T98, 9T31, 9T32 (Exp. 30/04/26); 2V13, 2V14, 2V15 (Exp. 30/06/26); 3V35 (Exp. 31/08/26); 3V36, 3V37 (Exp. 30/09/26); 5V45, 5V46, 9V12 (Exp. 31/03/27); 1X57, 1X70, 1X84 (Exp. 31/05/27)
- Distribution: Nationwide within the United States
The hazard
The product lacks assurance of sterility. According to FDA's FAERS database, there are 2,595 adverse-event reports naming this product, with 2,403 marked serious and 365 listing a death, though these are unverified reports not findings about this recall.
Context
GovInfoNow's records show other recent recalls of similar products include K.C. Pharmaceuticals Dry Eye Relief Eye Drops Recall (2026-03-03) and Clear Eyes Eye Drops Recalled for Sterility Risk (2026-07-29). Additional related actions include the Clear Eyes Eye Drops Recall: Lack of Sterility Risk reported on 2026-09-15.